Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03518606
Title Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours (MOVIE)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors UNICANCER
Indications

head and neck squamous cell carcinoma

Advanced Solid Tumor

breast cancer

prostate cancer

cervical cancer

Therapies

Durvalumab + Tremelimumab + Vinorelbine

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.